openPR Logo
Press release

Lawsuit filed for Investors in shares of Decision Diagnostics Corp. (OTC: DECN)

01-26-2021 10:34 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A lawsuit was filed on behalf of investors in Decision Diagnostics Corp. (OTC: DECN) shares.

A lawsuit was filed on behalf of investors in Decision Diagnostics Corp. (OTC: DECN) shares.

An investor, who purchased shares of Decision Diagnostics Corp. (OTC: DECN), filed a lawsuit over alleged violations of Federal Securities Laws by Decision Diagnostics Corp.

Investors who purchased shares of Decision Diagnostics Corp. (OTC: DECN) have certain options and for certain investors are short and strict deadlines running. Deadline: March 16, 2021. OTC: DECN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Westlake Village, CA based Decision Diagnostics Corp. develops smart phone based electronic medical record (EMR) technologies. Decision Diagnostics Corp claimed early in the year that it had a finger prick test that could detect the novel coronavirus and return results in less than one minute.

On December 17, 2020, the U.S. Securities and Exchange Commission ("SEC") filed a lawsuit alleging Decision’s claims were untrue.

Shares of Decision Diagnostics Corp. (OTC: DECN) declined from $0.45 per share in August 2020 to as low as $0.01 per share on December 21, 2020.

The plaintiff claims that between March 3, 2020 and December 17, 2020, the Defendants made false and/or misleading statements and failed to disclose to investors that Decision Diagnostics had not developed any viable COVID-19 test, much less a test that could detect COVID-19 in less than one minute, that the Company could not meet the FDA's EUA testing requirements for its purported COVID-19 test, that accordingly, Defendants had misrepresented the timeline within which it could realistically bring its COVID-19 test to market; (iv) all the foregoing subjected Defendants to an increased risk of regulatory oversight and enforcement, and that as a result, Defendants' public statements were materially false and misleading at all relevant times.

Those who purchased shares of Decision Diagnostics Corp. (OTC: DECN) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lawsuit filed for Investors in shares of Decision Diagnostics Corp. (OTC: DECN) here

News-ID: 2231207 • Views:

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) over possible Violations of Securities Laws
Investigation announced for Investors in shares of Lifecore Biomedical, Inc. (NA …
An investigation was announced for investors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) shares over potential securities laws violations by Lifecore Biomedical, Inc. Investors who purchased shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Lifecore Biomedical, Inc. regarding its business, its prospects and
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: DBI) over potential Wrongdoing by certain directors
Investigation announced for Investors in shares of Designer Brands Inc. (NYSE: D …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Designer Brands Inc. Investors who purchased shares of Designer Brands Inc. (NYSE: DBI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Designer Brands Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. Columbus,
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Innoviz Technologies Ltd. …
An investor, who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ), filed a lawsuit over alleged violations of Federal Securities Laws by Innoviz Technologies Ltd. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Innoviz Technologies Ltd. (NASDAQ: INVZ) have certain options and for certain investors are short and strict deadlines running. Deadline: May 14, 2024. NASDAQ: INVZ investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NASDAQ: IRBT)
Lawsuit filed for Investors who lost money with shares of iRobot Corporation (NA …
An investor, who purchased shares of iRobot Corporation (NASDAQ: IRBT), filed a lawsuit over alleged violations of Federal Securities Laws by iRobot Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of iRobot Corporation (NASDAQ: IRBT) have certain options and for certain investors are short and strict deadlines running. Deadline: May 7, 2024. NASDAQ: IRBT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)

All 5 Releases


More Releases for Decision

Management Decision Solutions Market Share, Size and Industry Growth - ACTICO Gm …
The Management Decision Solutions Industry report provides general consumption trends, sales techniques, and top Management Decision Solutions industry nations. The research examines providers in the global market segmentation, competition, and the macroeconomic climate. A complete Management Decision Solutions analysis takes into account population and business cycles, as well as market-specific microeconomic consequences. The global market research also includes a specific competition landscape section to help you better understand the Management
Decision Management Market share will continue to expand steadily through 2027 | …
Business rules, business intelligence, continuous improvement, artificial intelligence, and predictive analytics are among the methods used. It treats decisions as reusable assets and uses technology to automate the decision-making process at the Decision Management Market. This decision could be completely automated or offered as a set of options for a human to choose from. Decision Management Market is tailored to business managers in order to provide them more control over
Global Decision Making Software Market, Global Decision Making Software Industry …
The Decision-making Software market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Decision-Making Software Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Decision-making Software market. The report focuses on well-known providers in the global
Decision making software Market May See a Big Move | Major Giants TIBCO Software …
Latest released the research study on Global Decision making software Market, offers a detailed overview of the factors influencing the global business scope. Decision making software Market research report shows the latest market insights; current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Decision making software. The study covers emerging player’s
Clinical Decision Support Systems Market (2018-2024) - Impact of Covid-19 on Cli …
The Leading players are Wolters Kluwer Health (U.S.), Hearst Health (U.S.), and Elsevier B.V. (The Netherlands), Cerner Corporation (U.S.), McKesson Corporation (Change Healthcare) (U.S.), Epic Systems Corporation (U.S.), MEDITECH (U.S.), Philips Healthcare (The Netherlands). Meticulous Research® – leading global market research company is conducting a research study on Clinical Decision Support Systems Market to understand its growth and opportunity perspective for next 5 years. High incidences of medical errors fueled demand of
Holidaymakers concerned over Brexit decision
Holidaymakers have been left nursing serious concerns about the impact that victory for the Leave campaign in the EU Referendum will have on their future travel plans, according to a survey from leading independent travel agent Traveltext.co.uk Data compiled by the online agent following the much-discussed referendum revealed that more than 85% of respondents were worried in some way about the impact of Brexit on the travel industry. Those concerns